PVC Variability and Impact on Meeting Expert Consensus Cutoffs of ≥10,000 PVCs/day and ≥15% PVCs

Richard S Amara,Jason Appelbaum,Ameer Abutaleb,Rama vunnam,Stephen R. Shorofsky,Jeffrey N Rottman,Ardit Kacorri,Timm-Michael Dickfeld
DOI: https://doi.org/10.1101/2024.06.10.24308734
2024-06-11
Abstract:Background: Frequent PVCs have been associated with a reversible cardiomyopathy. Cutoffs of ≥10,000 PVCs/day and ≥15% PVCs have been suggested by the 2014 EHRA/HRS/APHRS and 2017 AHA/ACC/HRS Expert Consensus guidelines, respectively, for PVC suppression. Methods: 606 patients with 14 day ZIO® monitor datasets with ≥10,000 PVCs on at least one day were identified (2014 Guidelines Cohort). Of these patients, 325 had at least one day of ≥15% PVCs (2017 Guidelines Cohort). Analysis was performed on these cohorts to investigate the impact of PVC variability on meeting guideline thresholds. Results: Within the 2014 Guidelines Cohort, mean daily PVC burden was 12,188±8,300 [range 0-64,188]. Intra-patient daily PVCs were highly variable (median 3.6-fold change between max and min PVC days (Q1/3: 2.22/10.15) with instances of >10,000-fold change observed. 54.3% and 19.5% of patients had days with <5,000 and <1,000 PVCs, respectively. Even patients with days of 0 PVCs (0.5%) were observed. 72h monitoring detected 69% of patients with ≥10,000 PVCs/24h with an additional 2-4% of patients crossing the threshold each additional day. A bimodal distribution of number of days meeting PVC thresholds/corresponding PVC counts was observed, suggesting a previously unidentified pattern of distinct populations – "low frequency/low PVC" (≤3/14 above-threshold days/mean 12,342 PVCs those days) vs "high frequency/high PVC" (14/14 above-threshold days/mean 24,580 PVCs those days). The 2017 Guidelines Cohort demonstrated similar findings. Conclusion: Daily PVC burdens vary greatly. More sensitive detection of guideline-suggested cut-offs requires prolonged monitoring. Novel potential PVC patterns may allow for better identification of candidates for PVC suppression.
Cardiovascular Medicine
What problem does this paper attempt to address?